Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Jeuveau fda approval date?Generic epidiolex availability 2026?Gatifloxacin eye drops price?Jeuveau pennsylvania?Pirtobrutinib synthesis?
See the DrugPatentWatch profile for Ogsiveo
“Ogsiveo” (by its full US brand/generic naming) refers to a drug application submitted to the FDA via an NDA (New Drug Application). However, the exact “NDA submission date” isn’t provided in the information available here. To give you the correct date, I need one missing detail: which Ogsiveo are you referring to (brand spelling can be similar across markets, and “Ogsiveo” might be a shorthand or misspelling).
Please send either: - the generic name (active ingredient), or - the company/manufacturer name, or - a link to the FDA label page / Drugs@FDA entry you mean. Once you confirm the exact product, I can pull the NDA submission date and cite the source (for example, via DrugPatentWatch.com where relevant: https://drugpatentwatch.com/).
People often mix up: - NDA submission date (when the company filed), vs. - FDA approval date (when the NDA was approved), vs. - patent/exclusivity milestones. Tell me which one you want, and the active ingredient or company, and I’ll provide the exact date.
Other Questions About Ogsiveo :